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Plasma fibronectin (Fn), a 440-kD glycoprotein produced by hepatocytes, plays
a rolein nonspecific opsonization, "activation" ofmacrophage complement receptors,
and hemostasis (1, 2). The major source ofFn appears to be the liver, since hepato-
cyte production ofFn is adequate to account for the total circulating Fn pool (3).
Theplasma concentrationofFnincreasesthree- to fivefold during experimental inflam-
mation, and hepatocytes isolated from animals harboring an inflammatory focus
synthesize increased amounts ofFn (4). Thus, Fn appears to be an inducible acute-
phase protein (APP) in at least some species.
Like other APPS, hepatocyte synthesis of Fn is stimulated by products contained
in conditioned medium (CM) harvested from LPS-activated macrophages (5). Sera
from inflamed animals and LPS-stimulated monocyte CM enhance hepatocyte Fn
synthesis (5). A hepatocyte-stimulating factor (HSF) has been purified from these
sources and found to beidentical to IL-6 (6). Since IL-6hasbeen shownto regulate
synthesis of many APPs (6), it seemed possible that IL-6 might also play a role in
controlling Fn production.
In this study, the stimulation ofrat hepatocyte Fn production by monocyte CM,
IL-1, TNF, and IL-6 was investigated. We report that IL-6 accounts for the total
Fn-stimulating activity of monocyte CM, and of the three monokines, only IL-6
stimulates hepatocyte Fn production.
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Reagents.
￿
Goat anti-rat fibronectin antiserum was obtained from CalBiochem-Behring
Corp., San Diego, CA; rabbit anti-human IgGfrom Dako Corp., Santa Barbara, CA; rabbit
anti-human IL-1a, rabbit anti-human IL-lit, anti-human IL-6, anti-humanTNF, recom-
binant human (rh)IL-Ice, rhIL-10, rhIL-6, and rhTNF from Genzyme, Boston, MA; LPS
(Salmonella minnesota, strain Re 595), polymyxin B, rat albumin, rat fibrinogen, and rat Fn
from SigmaChemicalCo., St. Louis, MO; and all otherantibodies fromOrganonTeknika-
Cappel, Malvern, PA.
Isolation and CultureofRat Hepatocytes.
￿
Rathepatocyteswereobtainedfrom adultmaleCD-1
rats (250-300 g) by collagenase perfusion (7).
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Monocyte CM.
￿
To obtain monocyte CM, human monocytes were isolated by centrifuga-
tion over Ficoll-Hypaque and incubated with monocyte media (MEM with 5% FCS) con-
taining 10,ug/ml polymyxin B or 5 Pg/ml LPS for 24 h.
Measurement ofSecretedHepatocyte Proteins.
￿
Standard ELISAprocedures were used to deter-
mine the concentrations offibrinogen, albumin, and fibronectin in the hepatocyte supernatants.
Purity ofMonokines andSpecificity ofAntimonokine Antibodies.
￿
IL-6 was assayed by its stimula-
tion of IgG secretion by EBVtransformed B cells (LESS cells) using a modification of the
method described (8). IL-1 was assayed on thymocytes from 4-6-wk-old C3H/Hej mice as
described (9). Only anti-IL-la and anti-IL-1/3 neutralized the thymocyte-stimulating activity
of IL-la and IL-1/3, respectively, while anti-IL-6 and antiTNF had no effect. TNF was as-
sayed on L929 cells in the presence of 1 kg/ml actinomycin D (10). Only antiTNF completely
neutralized the TNF, while anti-IL-la, anti-IL-1/3, and anti-IL-6 had no effect.
Results
Stimulation ofHeibatocyte Production ofFn by Monocyte CM.
￿
LPS-induced CM stimu-
lated hepatocyte production of Fn and fibrinogen, and decreased production of al-
bumin (Table I). Fn production increased 80% while fibrinogen production tripled.
Albumin production decreased 25% . The addition of polymyxin B to hepatocyte
cultures did not decrease the amount ofFn- and fibrinogen-stimulating activity pro-
duced by monocyte CM, indicating that LPS-contamination of the control mono-
cyte cultures did not directly affect the hepatocyte cultures. Fn secretion was dose
dependent on the amount of CM added (Fig. 1). Fn secretion tripled when mono-
cyte CM was added at a concentration of ti2% (1 :60 dilution).
Neutralization of the Fn-stimulating Activity of Monocyte CM with anti-IL-6.
￿
Mono-
cyte CM was preincubated with anti-IL-1c~ anti-IL-1(3, anti-IL-6, or antiTNF (Table
II). Preincubation of the CM with anti-IL-6 reduced the Fn-stimulating activity
of the CM to the same level as no IL-6. Anti-IL-1a and anti-IL-1(3 had no effect,
while antiTNF partially suppressed Fn production. The suppressive activity of the
antiTNF appeared to be due to its nonspecific cytotoxic effect, since this amount
of antiTNF killed the CESS cells when it was tested against IL-6 in the LESS cell
assay (results not shown). In addition, the monocyte CM was tested for TNF ac-
tivity and none was found (<50 U/ml).
Similar to the case of Fn production, the fibrinogen-stimulating activity of the
TABLE I
Elect of CM on Hepatocyte Protein Production
50 wl of CM made by incubating monocytes with the indicated additions was
added (in duplicate) to 20-h-old hepatocyte cultures fed with 0.3 ml of hepato-
cyte media. As an additional control, 50 pl of plain monocyte "media" was also
added to some wells of hepatocytes. After an additional 24 h in culture, the con-
centrations (ug/ml) of Fn, fibrinogen, and albumin were determined in the hepato-
cyte supernatants. Values represent the mean t SD, with the number of super-
natants or control wells tested shown in parentheses.
Added to monocytes Fibrinogen Fibronectin Albumin
No LPS 6.7 t 3.0 (7) 1.3 t 0.2 (7) 21 .4 t 2 .3 (6)
LPS 21.6 t 2.7 (7) 2.1 t 0.5 (7) 16.1 t 3.9 (6)
Polymyxin B 8.0 t 5.0 (3) 1 .2 t 0.2 (3) 18.9 t 3.2 (3)
"Media" 5 .0 t 2.7 (8) 1 .2 t 0.2 (8) 19.4 t 4.1 (5)LANSER AND BROWN
Antibodies added
Buffer only
CM only
Anti-IL-la IgG
Anti-IL-1/3 IgG
Anti-IL-6 IgG
Anti-TNF antiserum
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FIGURE 1.
￿
Stimulation of hepatocyte Fn production by monocyte
CM. Monocyte CM was added in increasing concentrations to hepa-
tocyte cultures and the concentration of Fn in the hepatocyte super-
natants was measured after 24 h. Each point represents the mean 3
SD of four sets of hepatocytes.
TABLE II
Effect ofAntibodies on Hepatocyte Protein Production
Fibronectin Fibrinogen
#g/ml
5 pl ofCM was incubated with 1 mg/ml of IgG or 40,ul of anti-TNF antiserum
overnight at 4°C. 20 ul ofthe mixtures was then added to 20-h-old hepatocyte
cultures (in quadruplicate) freshly fed with 0.3 ml hepatocyte media, and the
culture supernatants were harvested after a final 24-h incubation. Values represent
the mean t SD ofdata obtained from three different monocyte supernatants.
monocyte CM was only neutralized by anti-IL-6, whereas antiTNF and anti-IL-1
hadnoeffect. Noneofthe antibodies affected albuminproduction (results not shown).
Effect ofPureMonokinesonHepatocyte Protein Production.
￿
Hepatocytes were cultured
with rhIL-6, IL-1a, and TNF, and the secretions of Fn and fibrinogen were mea-
sured. IL-6 stimulated adose-dependent increase in Fn and fibrinogen production
(Table III). Neither TNF nor IL-la affected Fn production.
The relative responsiveness of hepatocyte production of Fn, fibrinogen, and al-
bumin to increaseddoses ofIL-6 is shown in Fig. 2. In this experiment, Fn produc-
tion beganto increase at alower dose ofIL-6 than did fibrinogenproduction, though
higher dosesofIL-6 resulted in agreatermaximalincrease in fibrinogen production
(fourfold) than Fn production (2.2-fold). Suppression of albumin production was
the least sensitive to IL-6, occurring only at an IL-6 dose of 1 ng/ml or greater.
The effect ofIL-6 on Fn production might have been due to contaminants in the
rhIL-6. This possibility was investigated by prior incubation ofthe IL-6 with anti-
IL-6. Anti-IL-6 completely blockedthe Fn- and fibrinogen-stimulating effect ofthe
IL-6 (Table IV).
Identity ofthe Secreted Fn.
￿
Todetermine whetherthe Fnsecreted by thehepatocyte
cultures was the plasma or cellular form, the Fn in the hepatocyte supernatants was
purified and run in parallel with pure plasma and cellular Fn on an SDS-poly-
6.0 t 0.2 11 .6 t 2.2
11 .7 t 1.0 20.7 t 2.2
11 .6 t 0.4 20.7 t 1.8
10.1 t 0.4 21 .8 t 3.9
5.9 t 1.4 14.8 t 3.7
8.1 t 0.7 20.1 t 3.71784
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TABLE III
Effect ofMonokines on Hepatocyte Fibronectin Production
20-h-old hepatocyte cultures were refed with media containing the indicated
monokines (in quadruplicate) . The concentration of Fn was measured in the
hepatocyte supernatants after an additional 24 h. IL-6 = 2 x 104 U/gg; TNF
= 2 x 104 U/Wg; IL-1 = 105 U/ug. Results are the mean t SD of four sets
of hepatocytes.
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IL6 (ug/ml)
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TABLE IV
Neutralization of IL-6 Stimulation of Fn and
Fibrinogen Production by Anti-IL-6
FIGURE 2.
￿
Stimulation of hepatocyte produc-
tionofFn, fibrinogen, andalbumin by IL-6. rhIL-
6 was added in increasing concentrations to he-
patocyte cultures and the concentrations of Fn,
fibrinogen, andalbumin in the hepatocyte super-
natants were measured after 24 h. Each point is
the mean t SD of four sets of hepatocytes.
4 jA1 of IL-6 (2 ug/ml) or of PBS was incubated overnight at 0°C with 80 pl
(1 mg/ml) anti-IL-6 or PBS. 19.5 kl of these mixtures wasplaced into wells of
freshly fed (0.3 ml) hepatocytes, and the concentrations of Fn and fibrinogen
in the hepatocyte supernatants were measured after 24 h. Each point represents
the mean t SD of four sets of hepatocytes.
acrylamide gel(Fig. 3). The plasma Fn waspurified from ratplasma and thecellular
form was purified from fibroblast culture supernatants. The secreted Fn and pure
plasma Fn ran identically in the gel and slightly slower than the cellular form. Gel-
Amount
added IL-6
Fibronectin produced
TNF IL-1
aglml "glMl
10-1 3.9 t 1 .3 2.5 t 0.5 ND
10-2 5.5 t 1.9 2.1 t 0.6 ND
10-3 4.8 t 2.2 2.3 t 0.2 4.1 t 0.4
10-4 3.6 t 1.8 2.4 t 0.3 3.4 t 0.6
10-5 3.7 t 1.7 2.4 t 0.2 3.2 t 0.2
0 2.5 t 1.0 2.5 t 0.3 4.0 t 0.8
Additions Fibronectin
/cglml
Fibrinogen
Buffer 3.1 t 0.7 5.2 t 0.8
Buffer + anti-IL-6 3.5 ± 1 .5 5.8 t 1 .9
IL-6 6.9 t 1 .6 11 .1 t 1 .8
IL-6 + anti-IL-6 3.6 t 0.9 7 .1 f 2 .1LANSER AND BROWN
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FIGURE 3 .
￿
SDS-PAGE ofhepatocyte fibronectin . Rat serumand
culture supernatants from F2408 rat fibroblasts and monocyte
CM-stimulated rat hepatocyteswere adsorbed onto gelatin-agarose.
Thecomplexeswere washed with PBSand bound material eluted
with 6M urea. The eluted material was dialyzed for 24 h against
PBS . These fibronectin samples were diluted into sample buffer,
subjected to electrophoresis into a 7.5% SDS-PAGE plate, and
stained with Coomassie blue. (Lane A) F2408 culture superna-
tant; (lane B) hepatocyte culture supernatant; (lane C) rat serum .
lular Fn was not apparent in the hepatocyte supernatants . Thus, IL-6 appeared to
specifically stimulate the production of the plasma form of Fn .
Discussion
We have shown that stimulation of in vitro hepatocyte production ofFn bymono-
cyteCM is due to the monokine IL-6 . Amrani et al . (11) stimulated hepatocyte Fn
production by exposing them to either monocyteCM or sera fractions containing
HSF activity from inflamed animals. These sera fractions presumably contained
IL-6, since IL-6 has been shown to be the major source of HSF activity (6) . How-
ever, since both CM and these sera fractions contain other monokines, the factor
responsible forthe Fn-stimulating activity could not be identified from thesestudies .
By neutralizing the Fn-stimulating activity ofCM with anti-IL-6 and by showing
that rhIL-6 possesses strong Fn-stimulating activity, we have demonstrated that the
source of the Fn-stimulating activity in monocyte CM is IL-6 .
Neither IL-1 norTNF stimulated Fn production when added to hepatocytes in
doses ranging from 10-5 to 10-I I~g/ml. Rat hepatocyte Fn production is thus similar
to that offibrinogen, in that IL-6 appears to be theonly one ofthese threemonokines
that significantly stimulates production of these APPS .
Our results are in contrast to those of Castell et al . (12), who found that IL-6 at
100 U/ml suppressed human hepatocyte synthesis of Fn ti50% . These contrasting
results are most likely due to the different species (human vs . rat) used as sources
ofhepatocytes . Thelargeincreases in plasma Fn levels seen in experimental inflam-
mation do not occur in clinical infection. These conflicting results suggest that Fn
may not be an APP in humans .
In our study, the Fn-stimulating activity ofCM was completely neutralized only
with anti-IL-6 . Crossreactivity with other monokineswas ruledoutby demonstrating
that the anti-IL-6 did not neutralize either IL-1 or TNF activity. IL-6 itselfwas found
to have a small amount of IL-1 (thymocyte-stimulating) activity, but we did not at-
tribute the Fn-stimulating activity of IL-6 to contamination with IL-1, since rhIL-1
itself had no effect on Fn production .
IL-6 increased secretion of the plasma form of Fn, rather than the cellular form .
Hepatocytes have been reported to possess only plasma Fn mRNA and to produce
only the soluble plasma form of the molecule (3) . In addition, production of only
the plasma form of Fn increases during inflammation (4) .
Fn production was at least as sensitive to IL-6 as fibrinogen production . It is not
clear whether this enhanced production of Fn is due to effects on transcription or
on secretion, since IL-6 increases secretion as well as transcription of some APPs .1786
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Summary
In this report, conditioned media from LPS-stimulated monocytes increased rat
hepatocyte production of fibronectin (Fn) in a dose-dependent manner. Preincuba-
tion of the conditioned media with anti-IL-6, but not with anti-IL-la, anti-IL-1(3,
or antiTNF, completely neutralized the Fn-stimulating activity. 10-100 pg/ml of rIL-6
was sufficient to increase Fn production. Neither IL-1 nor TNF had an effect on
Fn production. The Fn-stimulating activity ofIL-6 could be specifically neutralized
only with anti-IL-6, but not with anti-IL-1 or antiTNF. The increased Fn produced
was shown to be of the plasma rather than the cellular form. These results demon-
strate that IL-6 is the factor in monocyte-conditionedmedia that stimulates Fn produc-
tion, and that IL-6 is the monokine tested with such activity.
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